These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9475248)

  • 41. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
    Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Target haematocrit during erythropoietin treatment in dialysis patients. Which value is 'true-functional haematocrit'?
    Vlassopoulos D; Sonikian M; Dardioti V; Hadjiconstantinou V
    Nephrol Dial Transplant; 1999 May; 14(5):1340-1. PubMed ID: 10344405
    [No Abstract]   [Full Text] [Related]  

  • 43. Circulating levels of thrombopoietin and erythropoietin in hemodialysis patients.
    Otsubo Y; Nitta K; Otsubo S; Kimata N; Miwa N; Watanabe Y; Uchida K; Kawashima A; Yumura W; Akiba T; Nihei H
    Acta Haematol; 2003; 109(4):209-11. PubMed ID: 12853697
    [No Abstract]   [Full Text] [Related]  

  • 44. Erythropoietin treatment in peritoneal dialysis patients.
    Nissenson AR
    Perit Dial Int; 1994; 14 Suppl 3():S63-9. PubMed ID: 7948280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant erythropoietin and chronic renal failure.
    Lundin AP
    Hosp Pract (Off Ed); 1991 Apr; 26(4):61-9. PubMed ID: 2010480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The use of recombinant erythropoietin with patients on programmed hemodialysis].
    Rozental' RL; Zezina LIu; Spudass AV
    Ter Arkh; 1991; 63(12):110-3. PubMed ID: 1803587
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hematopoietic effect of Radix angelicae sinensis in a hemodialysis patient.
    Bradley RR; Cunniff PJ; Pereira BJ; Jaber BL
    Am J Kidney Dis; 1999 Aug; 34(2):349-54. PubMed ID: 10430986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of anaemia resistant to conventional erythropoietin therapy with thymopentin in haemodialysis patients.
    Raiola P; Manzo M; Saggese A; Tomasino G; Cicchella T; Rambaldi M; Pisano M; Lizza B; Perna AF
    Nephrol Dial Transplant; 1995; 10 Suppl 6():48-50. PubMed ID: 8524495
    [No Abstract]   [Full Text] [Related]  

  • 49. [Erythropoietin, blood viscosity and hypertension in chronic kidney failure].
    Schaefer RM; Heidland A
    Dtsch Med Wochenschr; 1989 Jun; 114(26):1046-9. PubMed ID: 2661190
    [No Abstract]   [Full Text] [Related]  

  • 50. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
    von Appen K; Klinkmann H
    Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin therapy in chronic dialysis patients.
    Charytan C; Goldfarb-Rumyantzev A; Wang YF; Schwenk MH; Spinowitz BS
    Am J Nephrol; 1998; 18(6):498-503. PubMed ID: 9845824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
    Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
    Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.
    Fujita Y; Inoue S; Horiguchi S; Kuki A
    Miner Electrolyte Metab; 1995; 21(1-3):50-4. PubMed ID: 7565462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Recombinant human erythropoietin stimulates synthesis of fetal hemoglobin in patients with renal anemia treated by repeated hemodialysis].
    Hanicki Z; Sułowicz W; Stepniewski M; Kuźniewski M; Kraśniak A; Kopeć J; Cieszkowska U; Solarska K
    Pol Arch Med Wewn; 1991 Jun; 85(6):352-5. PubMed ID: 1716757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of thyroid dysfunction on erythropoietin dosage in hemodialysis patients.
    Ng YY; Lin HD; Wu SC; Yang CY; Yang WC; Liou HH; Hu FH; Hou CC; Tseng SS; Ku NY; Hsiao NY; Wu WC; Tu HM; Lien TJ; Lee CC; Tsang KK; Cheng CS; Hu J; Lin RP
    Thyroid; 2013 May; 23(5):552-61. PubMed ID: 23189968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Use of recombinant erythropoietin on secondary anemia in patients in the terminal phase of renal insufficiency on hemodialysis].
    Gasparović V; Puretić Z; Vrhovac B; Gjurasin M; Puljević D
    Acta Med Iugosl; 1990; 44(2):129-35. PubMed ID: 2353593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erythropoietin overview--1993.
    Nissenson AR
    Blood Purif; 1994; 12(1):6-13. PubMed ID: 7986477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reactivity of patients with maintenance hemodialysis to erythropoietin in the treatment of renal anemia.
    Hu JP; Cheng X; Xu XF; Yu GJ; Luo F; Zhang GS; Yang N; Shen P; Yan XY
    J Biol Regul Homeost Agents; 2016; 30(2):535-40. PubMed ID: 27358145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.